Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-alcoholic Fatty Liver Disease NAFLD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07497750
What this trial is testing

Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial

Who this might be right for
Non Alcoholic Fatty Liver Disease
University Hospital, Toulouse 216
Not applicableLooking for participantsNCT06619808
What this trial is testing

Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver DiseaseHepatic SteatosisNon-alcoholic Fatty Liver Diseases
Jinling Hospital, China 150
Testing effectiveness (Phase 2)Study completedNCT01147523
What this trial is testing

Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverSteatohepatitis
Aristotle University Of Thessaloniki 30
Large-scale testing (Phase 3)Looking for participantsNCT07581951
What this trial is testing

Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH

Who this might be right for
MASH - Metabolic Dysfunction-Associated SteatohepatitisNASH (Non-Alcoholic Steatohepatitis)
Haisco Pharmaceutical Group Co., Ltd. 886
Very early researchActive Not RecruitingNCT06113003
What this trial is testing

The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease

Who this might be right for
HIVNon-Alcoholic Fatty Liver DiseaseMetabolic-Associated Steatotic Liver Disease
Vanderbilt University Medical Center 63
Early research (Phase 1)Looking for participantsNCT05979389
What this trial is testing

Bicalutamide Therapy in Young Women With NAFLD and PCOS

Who this might be right for
NAFLDPCOS
University of California, San Francisco 50
Not applicableStudy completedNCT02044523
What this trial is testing

Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound

Who this might be right for
Hepatitis CHepatitis BNonalcoholic Fatty Liver Disease (NAFLD)+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 108
Not applicableUnknownNCT05358496
What this trial is testing

Study of Neutrophils and Circulating Platelets in Correlation With the Activity of T Lymphocytes in Patients With NAFLD (Nonalcoholic Fatty Liver Disease)

Who this might be right for
NAFLD- Non Alcoholic Fatty Liver Disease
University of L'Aquila 80
Not applicableLooking for participantsNCT06704321
What this trial is testing

Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Valbiotis 70
Testing effectiveness (Phase 2)Study completedNCT04173065
What this trial is testing

Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Viking Therapeutics, Inc. 248
Post-approval studies (Phase 4)Study completedNCT00160407
What this trial is testing

Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Fatty LiverHepatitis
St. Louis University 50
Testing effectiveness (Phase 2)Study completedNCT04555434
What this trial is testing

Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Chuncheon Sacred Heart Hospital 89
Not applicableLooking for participantsNCT06332677
What this trial is testing

Target of Suv420h1/2 in Hepatocytes

Who this might be right for
NAFLD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 260
Testing effectiveness (Phase 2)Study completedNCT01553500
What this trial is testing

Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease

Who this might be right for
Metabolic SyndromeNon Alcoholic Fatty Liver DiseaseInsulin Resistance
Bambino Gesù Hospital and Research Institute 66
Large-scale testing (Phase 3)Study completedNCT01934777
What this trial is testing

Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis

Who this might be right for
Fatty LiverLiver FibrosisObesity+2 more
Bambino Gesù Hospital and Research Institute 60
Early research (Phase 1)Study completedNCT06044467
What this trial is testing

The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects

Who this might be right for
Nonalcoholic Fatty Liver Disease
ChemomAb Ltd. 16
Early research (Phase 1)Ended earlyNCT05668936
What this trial is testing

A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants

Who this might be right for
Non-alcoholic Steatohepatitis
AstraZeneca 31
Testing effectiveness (Phase 2)UnknownNCT05402371
What this trial is testing

Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Fibrosis, LiverNAFLD
Hepion Pharmaceuticals, Inc. 120
Not applicableUnknownNCT03801577
What this trial is testing

Hepaxa Management of Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic Fatty LiverNASH - Nonalcoholic Steatohepatitis
BASF AS 50
Testing effectiveness (Phase 2)Study completedNCT04140123
What this trial is testing

Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Guangdong Raynovent Biotech Co., Ltd 37
Next Page